Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/941631c2-2f77-4847-861c-5f600831df43/

NX1

Nexalis Therapeutics Limited
Chart
0.02 AUD
Latest Week 2026-06-05
Snapshot 2026-06-07 · 0.0w · Fresh
0.28
OS Score
33.0%
Value
32.0%
Quality
33.0%
Momentum
1/9
F-Score
0.325
QV
Strategy Eligibility
0 of 23 passing
OS Composite
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
33.0%ile
FCF Yield
-0.203
SH Yield
-0.117
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
67.00000000
/100 — 1=cheapest
VC2 (Trending Value)
66.00000000
/100
VC3 (Buyback)
66.00000000
/100
Negative FCF yield (-20.3%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
32.0%ile
ROE
1.378
ROA
-1.340
Current
0.58
F-Score
1/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
5yr Consist
No
ROE of 138% is exceptional. F-Score of 1/9 flags fundamental deterioration — multiple signals are weakening.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
33.0%ile
Vol 252d
113.5%
Vol 60d
116.5%
↑ Expanding
Max DD 12M
-39.3%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
OS
Composite & Factor Heatmap
All factors at a glance
0.28
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 145 peers
Sector Value %ile
37.7%
Sector Quality %ile
38.4%
Sector Avg OS
45.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
VLS Vita Life Sciences Limited 98.0% 93.0% 98.0% 91.0%
SDI SDI Limited 95.0% 86.0% 87.0% 94.0%
TRI TrivarX Limited 94.0% 82.0% 81.0% 82.0%
TRU TruScreen Group Limited 94.0% 82.0% 80.0% 82.0%
VBS Vectus Biosystems Limited 92.0% 80.0% 79.0% 80.0%
VFX VISIONFLEX FPO [VFX] 92.0% 81.0% 79.0% 81.0%
ACR Acrux Limited 91.0% 79.0% 78.0% 79.0%
ACW Actinogen Medical Limited 91.0% 79.0% 78.0% 79.0%
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
0.0% avg (2 factors)
Quality
D
34.5% avg (3 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.280—1
Value %ile0.330—0
Quality %ile0.320—0
Momentum %ile0.330—0
F-Score1.000—1
Confidence0.325—1
Volatility1.135—1
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
FCF Yield
-20.3%
Shareholder Yield
Div + net buyback / mktcap
-11.7%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
137.8%
Return on Assets
-134.0%
Current Ratio
0.58
External Financing
Net issuance — lower=better
0.491
MomentumPrice trend strength over different horizons
Growth & StabilityEarnings trajectory, consistency, and capital allocation
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
1
Dividend Yield
0.0%
Buyback Yield
-11.7%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
67
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
66
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
66
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity